Stockreport

BRIEF-Dimension Therapeutics to pay $2.9 mln to Regenxbio incase merger terminates [Reuters]

DIMENSION THERAPEUTICS  (DMTX) 
US:NASDAQ Investor Relations: investors.dimensiontx.com
PDF * Dimension Therapeutics - Upon termination of merger ,under specified circumstances, co required to pay Regenxbio termination fee $2.9 million- SEC filing Source text: [Read more]